# ProFrac Holding Corp.: financial statements, quarterly

ACDC · Nasdaq · CIK 1881487 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acdc.md) · [Financials](/companies/acdc/financials.md) · [Filings](/companies/acdc/filings.md) · [Insiders](/companies/acdc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acdc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [574](/filings/0000950170-24-122270.md) | [489 d](/filings/0001193125-26-106120.md) | [582](/filings/0000950170-25-065625.md) | [579](/filings/0000950170-25-104997.md) | [575](/filings/0001193125-25-274194.md) | [455 d](/filings/0001193125-26-106120.md) | [600](/filings/0001193125-26-214605.md) | [502](/filings/0001193125-26-337969.md) | [403](/filings/0001193125-25-274194.md) | [437 d](/filings/0001193125-26-106120.md) | [450](/filings/0001193125-26-214605.md) | [498](/filings/0001193125-26-337969.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [52.7](/filings/0000950170-24-122270.md) | [47.6 d](/filings/0001193125-26-106120.md) | [50.6](/filings/0000950170-25-065625.md) | [54.1](/filings/0000950170-25-104997.md) | [51.9](/filings/0001193125-25-274194.md) | [48.0 d](/filings/0001193125-26-106120.md) | [53.6](/filings/0001193125-26-214605.md) | [51.4](/filings/0001193125-26-337969.md) | [43.0](/filings/0001193125-25-274194.md) | [42.5 d](/filings/0001193125-26-106120.md) | [43.6](/filings/0001193125-26-214605.md) | [43.7](/filings/0001193125-26-337969.md) |
| Operating income | $m | [20.5](/filings/0000950170-24-122270.md) | [(14.3) d](/filings/0001193125-26-106120.md) | [39.9](/filings/0000950170-25-065625.md) | [(49.2)](/filings/0000950170-25-104997.md) | [(4.3)](/filings/0001193125-25-274194.md) | [(46.8) d](/filings/0001193125-26-106120.md) | [16.0](/filings/0001193125-26-214605.md) | [(58.0)](/filings/0001193125-26-337969.md) | [(78.8)](/filings/0001193125-25-274194.md) | [(105) d](/filings/0001193125-26-106120.md) | [(46.4)](/filings/0001193125-26-214605.md) | [(37.9)](/filings/0001193125-26-337969.md) |
| Interest expense | $m | [40.2](/filings/0000950170-24-122270.md) | [38.8 d](/filings/0001193125-26-106120.md) | [37.6](/filings/0000950170-25-065625.md) | [39.6](/filings/0000950170-25-104997.md) | [40.6](/filings/0001193125-25-274194.md) | [38.8 d](/filings/0001193125-26-106120.md) | [35.9](/filings/0001193125-26-214605.md) | [35.1](/filings/0001193125-26-337969.md) | [34.5](/filings/0001193125-25-274194.md) | [33.3 d](/filings/0001193125-26-106120.md) | [32.8](/filings/0001193125-26-214605.md) | [33.2](/filings/0001193125-26-337969.md) |
| Income tax | $m | [(6.7)](/filings/0000950170-24-122270.md) | [(8.4) d](/filings/0001193125-26-106120.md) | [0.3](/filings/0000950170-25-065625.md) | [(23.7)](/filings/0000950170-25-104997.md) | [(1.5)](/filings/0001193125-25-274194.md) | [17.9 d](/filings/0001193125-26-106120.md) | [0.3](/filings/0001193125-26-214605.md) | [4.4](/filings/0001193125-26-337969.md) | [(20.2)](/filings/0001193125-25-274194.md) | [2.6 d](/filings/0001193125-26-106120.md) | [1.6](/filings/0001193125-26-214605.md) | [3.6](/filings/0001193125-26-337969.md) |
| Net income | $m | [(18.9)](/filings/0000950170-24-122270.md) | [(97.9) d](/filings/0001193125-26-106120.md) | [1.8](/filings/0000950170-25-065625.md) | [(66.7)](/filings/0000950170-25-104997.md) | [(45.2)](/filings/0001193125-25-274194.md) | [(105) d](/filings/0001193125-26-106120.md) | [(17.5)](/filings/0001193125-26-214605.md) | [(108)](/filings/0001193125-26-337969.md) | [(101)](/filings/0001193125-25-274194.md) | [(143) d](/filings/0001193125-26-106120.md) | [(83.5)](/filings/0001193125-26-214605.md) | [(79.7)](/filings/0001193125-26-337969.md) |
| Diluted EPS | $ per share | [(0.17)](/filings/0000950170-24-122270.md) | not reported | [0.00](/filings/0000950170-25-065625.md) | [(0.42)](/filings/0000950170-25-104997.md) | [(0.29)](/filings/0001193125-25-274194.md) | not reported | [(0.12)](/filings/0001193125-26-214605.md) | [(0.68)](/filings/0001193125-26-337969.md) | [(0.60)](/filings/0001193125-25-274194.md) | not reported | [(0.47)](/filings/0001193125-26-214605.md) | [(0.45)](/filings/0001193125-26-337969.md) |
| Basic EPS | $ per share | [(0.17)](/filings/0000950170-24-122270.md) | not reported | [0.00](/filings/0000950170-25-065625.md) | [(0.42)](/filings/0000950170-25-104997.md) | [(0.29)](/filings/0001193125-25-274194.md) | not reported | [(0.12)](/filings/0001193125-26-214605.md) | [(0.68)](/filings/0001193125-26-337969.md) | [(0.60)](/filings/0001193125-25-274194.md) | not reported | [(0.47)](/filings/0001193125-26-214605.md) | [(0.45)](/filings/0001193125-26-337969.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.1](/filings/0000950170-24-122270.md) | [25.3](/filings/0000950170-25-036251.md) | [28.3](/filings/0000950170-24-057774.md) | [24.0](/filings/0000950170-24-094812.md) | [25.5](/filings/0000950170-24-122270.md) | [14.8](/filings/0001193125-26-106120.md) | [16.0](/filings/0000950170-25-065625.md) | [26.0](/filings/0001193125-26-337969.md) | [58.0](/filings/0001193125-25-274194.md) | [22.9](/filings/0001193125-26-337969.md) | [33.5](/filings/0001193125-26-214605.md) | [18.8](/filings/0001193125-26-337969.md) |
| Current assets | $m | [679](/filings/0000950170-23-062012.md) | [638](/filings/0000950170-25-036251.md) | [665](/filings/0000950170-24-057774.md) | [704](/filings/0000950170-24-094812.md) | [680](/filings/0000950170-24-122270.md) | [574](/filings/0001193125-26-106120.md) | [670](/filings/0000950170-25-065625.md) | [580](/filings/0000950170-25-104997.md) | [541](/filings/0001193125-25-274194.md) | [484](/filings/0001193125-26-337969.md) | [534](/filings/0001193125-26-214605.md) | [572](/filings/0001193125-26-337969.md) |
| Total assets | $m | [3,222](/filings/0000950170-23-062012.md) | [3,071](/filings/0000950170-25-036251.md) | [3,007](/filings/0000950170-24-057774.md) | [3,164](/filings/0000950170-24-094812.md) | [3,136](/filings/0000950170-24-122270.md) | [2,988](/filings/0001193125-26-106120.md) | [3,021](/filings/0000950170-25-065625.md) | [2,831](/filings/0000950170-25-104997.md) | [2,742](/filings/0001193125-25-274194.md) | [2,573](/filings/0001193125-26-337969.md) | [2,551](/filings/0001193125-26-214605.md) | [2,508](/filings/0001193125-26-337969.md) |
| Current liabilities | $m | [704](/filings/0000950170-23-062012.md) | [649](/filings/0000950170-25-036251.md) | [624](/filings/0000950170-24-057774.md) | [700](/filings/0000950170-24-094812.md) | [715](/filings/0000950170-24-122270.md) | [660](/filings/0001193125-26-106120.md) | [685](/filings/0000950170-25-065625.md) | [640](/filings/0000950170-25-104997.md) | [596](/filings/0001193125-25-274194.md) | [597](/filings/0001193125-26-337969.md) | [651](/filings/0001193125-26-214605.md) | [677](/filings/0001193125-26-337969.md) |
| Total liabilities | $m | [1,860](/filings/0000950170-23-062012.md) | [1,742](/filings/0000950170-25-036251.md) | [1,673](/filings/0000950170-24-057774.md) | [1,891](/filings/0000950170-24-094812.md) | [1,906](/filings/0000950170-24-122270.md) | [1,849](/filings/0001193125-26-106120.md) | [1,897](/filings/0000950170-25-065625.md) | [1,812](/filings/0000950170-25-104997.md) | [1,721](/filings/0001193125-25-274194.md) | [1,692](/filings/0001193125-26-337969.md) | [1,766](/filings/0001193125-26-214605.md) | [1,791](/filings/0001193125-26-337969.md) |
| Long-term debt | $m | [934](/filings/0000950170-23-062012.md) | [942](/filings/0000950170-25-036251.md) | [912](/filings/0000950170-24-057774.md) | [1,025](/filings/0000950170-24-094812.md) | [1,001](/filings/0000950170-24-122270.md) | [944](/filings/0001193125-26-106120.md) | [975](/filings/0000950170-25-065625.md) | [948](/filings/0000950170-25-104997.md) | [912](/filings/0001193125-25-274194.md) | [876](/filings/0001193125-26-337969.md) | [908](/filings/0001193125-26-214605.md) | [918](/filings/0001193125-26-337969.md) |
| Current portion of debt | $m | [123](/filings/0000950170-23-062012.md) | [126](/filings/0000950170-25-036251.md) | [136](/filings/0000950170-24-057774.md) | [174](/filings/0000950170-24-094812.md) | [172](/filings/0000950170-24-122270.md) | [160](/filings/0001193125-26-106120.md) | [147](/filings/0000950170-25-065625.md) | [131](/filings/0000950170-25-104997.md) | [154](/filings/0001193125-25-274194.md) | [145](/filings/0001193125-26-337969.md) | [151](/filings/0001193125-26-214605.md) | [160](/filings/0001193125-26-337969.md) |
| Shareholders' equity | $m | [1,250](/filings/0000950170-23-062012.md) | [1,211](/filings/0000950170-25-036251.md) | [1,214](/filings/0000950170-24-057774.md) | [1,147](/filings/0000950170-24-094812.md) | [1,102](/filings/0000950170-24-122270.md) | [1,007](/filings/0001193125-26-106120.md) | [988](/filings/0000950170-25-065625.md) | [876](/filings/0000950170-25-104997.md) | [862](/filings/0001193125-25-274194.md) | [718](/filings/0001193125-26-337969.md) | [617](/filings/0001193125-26-214605.md) | [543](/filings/0001193125-26-337969.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [124 d](/filings/0000950170-24-122270.md) | [42.7 d](/filings/0001193125-26-106120.md) | [79.1](/filings/0000950170-25-065625.md) | [114 d](/filings/0000950170-25-104997.md) | [98.2 d](/filings/0001193125-25-274194.md) | [76.5 d](/filings/0001193125-26-106120.md) | [38.7](/filings/0001193125-26-214605.md) | [96.7 d](/filings/0001193125-26-337969.md) | [4.6 d](/filings/0001193125-25-274194.md) | [49.5 d](/filings/0001193125-26-106120.md) | [9.3](/filings/0001193125-26-214605.md) | [22.9 d](/filings/0001193125-26-337969.md) |
| Capital expenditure | $m | [52.6 d](/filings/0000950170-24-122270.md) | [33.1 d](/filings/0001193125-26-106120.md) | [59.9](/filings/0000950170-25-065625.md) | [61.9 d](/filings/0000950170-25-104997.md) | [70.0 d](/filings/0001193125-25-274194.md) | [63.2 d](/filings/0001193125-26-106120.md) | [52.5](/filings/0001193125-26-214605.md) | [42.8 d](/filings/0001193125-26-337969.md) | [38.0 d](/filings/0001193125-25-274194.md) | [36.6 d](/filings/0001193125-26-106120.md) | [40.7](/filings/0001193125-26-214605.md) | [31.7 d](/filings/0001193125-26-337969.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.0](/filings/0000950170-23-010960.md) | [54.9](/filings/0000950170-24-057774.md) | [149](/filings/0000950170-24-094812.md) | [159](/filings/0000950170-24-122270.md) | [160](/filings/0000950170-25-065625.md) | [160](/filings/0000950170-25-104997.md) | [160](/filings/0001193125-25-274194.md) | [160](/filings/0001193125-26-214605.md) | [160](/filings/0001193125-26-337969.md) | [171](/filings/0001193125-25-274194.md) | [182](/filings/0001193125-26-214605.md) | [182](/filings/0001193125-26-337969.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 182,122,762 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337969.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.